EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (3 hours ago)
Learn more about our recently launched application at #Chemspec Europe 2019. SaferSkin uses an ITS approach to prov… https://t.co/AVDsDMgrVE
Edelweiss Connect (3 hours ago)
We are excited to be at @ChemspecEurope this week! Stop by Stand B316 to speak with the Edelweiss team. #basel… https://t.co/qFlOlHTOfO
Edelweiss Connect (3 hours ago)
RT @openrisknet: Did you miss the live webinar yesterday on the Deploying Applications to an OpenRiskNet Virtual Environment https://t.co/w…
Edelweiss Connect (2 weeks ago)
RT @LucianFarcal: Discover our @EUNanoSafety stand activities at @ENF_2019 in Bucharest, 12-14 June: https://t.co/sVFWSdmEqo Learn more abo…
Edelweiss Connect (2 weeks ago)
Some benefits of SaferSkin™ = No #animaltesting required, saves you time, increases your accuracy, decreases the ri… https://t.co/5Xbo780fRR

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 633 29 78
  • Email: info@edelweissconnect.com

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA
  • Phone: +1 252 654 9003
  • Email: info@edelweissconnect.com